financetom
Business
financetom
/
Business
/
Generac's Q4 Adjusted Earnings, Net Sales Fall; Initiates 2026 Sales Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Generac's Q4 Adjusted Earnings, Net Sales Fall; Initiates 2026 Sales Guidance
Mar 11, 2026 3:39 AM

06:19 AM EST, 02/11/2026 (MT Newswires) -- Generac Holdings ( GNRC ) reported Q4 adjusted net income Wednesday of $1.61 per diluted share, down from $2.80 a year earlier.

Analysts polled by FactSet expected $1.77.

Net sales for the quarter ended Dec. 31 were $1.09 billion, compared with $1.23 billion a year earlier.

Analysts surveyed by FactSet expected $1.16 billion.

For 2026, the company said it expects net sales growth in the mid-teens percent. Analysts polled by FactSet expect $4.72 billion.

Shares of the company were down over 4% in recent Wednesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Newmark Buys Catella Valuation Advisory
Newmark Buys Catella Valuation Advisory
Nov 24, 2025
10:10 AM EST, 11/24/2025 (MT Newswires) -- Newmark ( NMRK ) said Monday it acquired Catella Valuation Advisory, a French real estate valuation and advisory firm that operates in assets like office, retail, industrial, residential, and others. Financial terms of the acquisition were not provided. The entire Catella Valuation Advisory team will join Newmark ( NMRK ) in the coming...
BlackRock, AccessFintech Form Partnership to Enhance Post-Trade Collaboration
BlackRock, AccessFintech Form Partnership to Enhance Post-Trade Collaboration
Nov 24, 2025
10:08 AM EST, 11/24/2025 (MT Newswires) -- BlackRock ( BLK ) and AccessFintech said Monday they have entered a partnership to integrate AccessFintech's Synergy Network with BlackRock's ( BLK ) Aladdin platform to enhance post trade collaboration between buy-side firms and more than 250 capital markets and asset servicing institutions. The companies said the partnership will provide better bilateral connectivity,...
Jyong Biotech to Evaluate Licensing Deal for MCS-2 Drug Candidate in South Korea
Jyong Biotech to Evaluate Licensing Deal for MCS-2 Drug Candidate in South Korea
Nov 24, 2025
10:08 AM EST, 11/24/2025 (MT Newswires) -- Jyong Biotech ( MENS ) said Monday that it signed a non-binding letter of intent with a South Korean pharmaceutical company to assess the potential in-licensing and development of Jyong Biotech's ( MENS ) MCS-2 candidate in South Korea. The company said definitive terms are still being negotiated and the LOI remains subject...
Form 8.3
Form 8.3
Nov 24, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if...
Copyright 2023-2026 - www.financetom.com All Rights Reserved